Ovoca Bio plc (ISE:OVXA) entered into a conditional Letter of Intent to acquire Tadeen International Limited for $1.5 million on May 7, 2025. Pursuant to the Proposed Acquisition, Ovoca will acquire all of the issued Ordinary Shares of Tadeen together with Tadeen's debts and liabilities in exchange for the ordinary shares in the capital of Ovoca (the "Ovoca Ordinary Shares"), resulting in a takeover by Ovoca of Tadeen; It is intended that the current shareholders and creditors of Tadeen will receive an aggregate maximum of $1.53 million ("Consideration") in the form of Ovoca Ordinary Shares; The Company also today announces its intention to cancel its admission to trading on Euronext Growth, Concurrent to closing of the RTO, if considered reasonable to be done, Ovoca will do a three for one share consolidation of the outstanding Ovoca Ordinary Shares; Following the Proposed Acquisition and completion of the RTO the enlarged group will be renamed "Talisman Metals plc" or such other name as by may determined by Ovoca, to align the with the future business strategy and operations of the Company going forward; and The LOI contains a number of conditions including completion of mutual satisfactory due diligence, compliance with all regulatory requirements, the entering into of an agreeable Definitive Agreement ("SPA) along with other standard terms. The Company expects to undertake a fundraise in connection with the RTO. Should the Acquisition be completed, it is anticipated that Tadeen shareholders would own approximately 40% of the enlarged issued share capital of the group on Admission. Ovoca and the shareholders of Tadeen expect to agree to the terms of a binding Share Purchase Agreement ("SPA") in Q2 2025.
Ovoca has appointed Beaumont Cornish Limited as its new Financial and Nominated Adviser, or "Nomad" to lead the RTO and re-admission to AIM of the enlarged group as well as its Broker.
Ovoca Bio plc (ISE:OVXA) completed the acquisition of Tadeen International Limited on November 13, 2025. Beaumont Cornish Limited will continue to act as the Company's Nominated Adviser.
Ovoca Bio plc acquired Tadeen International Limited.
Published on 11/12/2025
S&P Capital IQ
Share
© S&P Capital IQ -
2025
Share
















